儿童特应性皮炎患者接触过敏的儿科接触性皮炎注册数据
该回顾性病例 review 分析了 2015 年全美 84 名医疗提供者登记的 1142 例 18 岁以下儿童斑贴试验数据,旨在探讨特应性皮炎(AD)与过敏性接触性皮炎(ACD)的关联。结果显示,AD 组患儿年龄更小(10.5 vs 11.8 岁,P<.001)、皮炎病史更长(3.5 vs 1.8 年,P<.001),亚裔或非裔更易共患 AD,且 AD 组对椰油酰胺丙基甜菜碱、羊毛脂等护肤相关过敏原的反应频率更高。
要点
- AD 患儿应警惕接触过敏,尤其对护肤用品中过敏原。
- 亚裔或非裔儿童更易共患 AD 与 ACD。
- AD 组对椰油酰胺丙基甜菜碱、羊毛脂等反应频率更高。
核心结论
- AD 患儿对护肤用品中常见过敏原显示出显著的反应模式,提示需关注 AD 与 ACD 的交互作用。
主要发现
- AD 组患儿较非 AD 组年龄小 1.3 岁(10.5 vs 11.8 岁,P<.001),皮炎病史更长(3.5 vs 1.8 年,P<.001)。
- 亚裔(OR 1.92,95%CI 1.20-3.10,P=.008)和非裔(OR 4.09,95%CI 2.70-6.20,P<.001)更易共患 AD。
- AD 组对椰油酰胺丙基甜菜碱、羊毛脂、替可的松特戊酸酯和 parthenolide 反应频率增高。
- AD 组对甲基异噻唑啉酮、钴和重铬酸钾反应频率较低。
临床怎么用
- 对 AD 患儿,尤其是亚裔或非裔、病史较长者,应考虑斑贴试验排查接触过敏。
- 选择护肤用品时注意规避椰油酰胺丙基甜菜碱、羊毛脂等常见过敏原。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Atopic dermatitis (AD) and allergic contact dermatitis (ACD) have a dynamic relationship not yet fully understood. Investigation has been limited thus far by a paucity of data on the overlap of these disorders in pediatric patients. OBJECTIVE: To use data from the Pediatric Contact Dermatitis Registry to elucidate the associations and sensitizations among patients with concomitant AD and ACD. DESIGN, SETTING, AND PARTICIPANTS: This retrospective case review examined 1142 patch test cases of children younger than 18 years, who were registered between January 1, 2015, and December 31, 2015, by 84 health care providers (physicians, nurse practitioners, physician assistants) from across the United States. Data were gathered electronically from multidisciplinary providers within outpatient clinics throughout the United States on pediatric patients (ages 0-18 years). EXPOSURES: All participants were patch-tested to assess sensitizations to various allergens; history of AD was noted by the patch-testing providers. MAIN OUTCOMES AND MEASURES: Primary outcomes were sensitization rates to various patch-tested allergens. RESULTS: A total of 1142 patients were evaluated: 189 boys (34.2%) and 363 girls (65.8%) in the AD group and 198 boys (36.1%) and 350 girls (63.9%) in the non-AD group (data on gender identification were missing for 17 patients). Compared with those without AD, patch-tested patients with AD were 1.3 years younger (10.5 vs 11.8 years; P < .001) and had longer history of dermatitis (3.5 vs 1.8 years; P < .001). Patch-tested patients designated as Asian or African American were more likely to have concurrent AD (odds ratio [OR], 1.92; 95% CI, 1.20-3.10; P = .008; and OR, 4.09; 95% CI, 2.70-6.20; P <.001, respectively). Patients with AD with generalized distribution were the most likely to be patch tested (OR, 4.68; 95% CI, 3.50-6.30; P < .001). Patients with AD had different reaction profiles than those without AD, with increased frequency of reactions to cocamidopropyl betaine, wool alcohol, lanolin, tixocortol pivalate, and parthenolide. Patients with AD were also noted to have lower frequency of reaction to methylisothiazolinone, cobalt, and potassium dichromate. CONCLUSIONS AND RELEVANCE: Children with AD showed significant reaction patterns to allergens notable for their use in skin care preparations. This study adds to the current understanding of AD in ACD, and the continued need to investigate the interplay between these disease processes to optimize care for pediatric patients with these conditions.
引用
- Jacob SE, McGowan M, Silverberg NB, et al. Pediatric Contact Dermatitis Registry Data on Contact Allergy in Children With Atopic Dermatitis. JAMA Dermatol. 2017. PMID: 28241280. doi:10.1001/jamadermatol.2016.6136
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。